Академический Документы
Профессиональный Документы
Культура Документы
Application Note
External Equivalent amounts of Amoxicillin and Clavulanic acid were mixed with
Surface Area the remaining excipients to get dry powder suspension as shown in the
table here. The formulation was evaluated for assay, content uniformity,
dispersability, flowability, pourability, and viscosity of final liquid
Solving the Moisture Challenge suspension.
Beta-lactam antibiotics such as Amoxicillin, Cefuroxime, and SYLOID® AL1-FP silica’s surface area and highly active surface work as
Cefixime are often formulated with Potassium Clavulanate to avoid a very effective desiccant. This helps to protect the highly hygroscopic
degradation from β-lactamase enzymes. Potassium Clavulanate is Potassium Clavulanate from hydrolysis and provides continued
highly hygroscopic in nature and is hydrolyzed in the presence of stabilization of β-lactam antibiotics. With a high absorption capacity for
moisture, which ultimately affects the efficiency of the antibiotics. As water vapor at low relative humidity SYLOID® AL1-FP silica’s surface
a result, manufacturers of β-lactam antibiotics look to dry powder area and active surface work as a very effective desiccant to protect the
formulations which can be easily converted to liquid suspension highly hygroscopic Potassium Clavulanate from hydrolysis and provide
before administration. continued stabilization of β-lactam antibiotics.
The challenge is to stabilize the antibiotics in this powder form. The high absorption capacity allows the silica to help maintain a very
Grace’s SYLOID® AL1-FP silica works as a uniquely effective moisture low humidity microenvironment near powder particles, reducing water
absorbent that helps maintain stability while SYLOID® 244FP silica available to degrade the ingredients. In a formulation, the ratio of
is commonly used to maintain powder flow, uniformity, and to help SYLOID® AL1-FP silica to Potassium Clavulanate is optimized at 1:1.
prevent caking.
SYLOID® 244FP silica helped ensure content uniformity, powder flow
property, to avoid agglomeration of powder and as a suspension aid.
Over a period of one month at room temperature and at 40°C with
1
75% relative humidity, we found no significant change in both Potassium
Clavulanate and Amoxicillin drug content. The combination of SYLOID®
AL1-FP silica and SYLOID® 244FP silica was ideal for stabilizing dry powder
formulations containing highly hygroscopic compounds.
80
60
40
20
0
Amoxicillin Potassium Clavulanate
grace.com
Grace Corporate Headquarters Regional Locations